worth a listen to the earnings call. ceo speaks so well. he seems super switched on and addresses all the questions and concerns brilliantly.. re recall, weight loss drugs...
not just a cpap company.e.g. copd
investing in alternative devices and treatments.
growing market with big pharma and big tech increasing the market opportunity.
ai algorithms redefining customers service.
buidling the software as service
recall costs already accounted with very small minority of patients with metal implants.
weigh loss drugs channeling more patients into the wider healthcare system
yes 47c per share.
Ann: ResMed Announces Results for the Second Quarter of FY2024, page-17
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$31.73 |
Change
0.060(0.19%) |
Mkt cap ! $20.14B | |||
| Open | High | Low | Value | Volume |
| $31.81 | $31.89 | $31.62 | $25.45M | 801.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6917 | $31.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.77 | 4586 | 1 |
View Market Depth
| Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$31.81 |
Change
0.060 ( 0.35 %) |
||||
| Open | High | Low | Volume | ||
| $31.73 | $31.84 | $31.62 | 459538 | ||
| Last updated 15.59pm 12/06/2024 ? | |||||
| RMD (ASX) Chart |